What’s next on nonproliferation and international security, in Washington and around the globe.
— August 12: Russian President Vladimir Putin is expected to meet with his new Iranian counterpart, Hassan Rouhani, in a meeting in Tehran. The tet-a-tet comes just as President Obama has spurned a planned summit with Putin but might be entertaining the idea of an eventual sit-down with Rouhani — if conditions evolve sufficiently to allow it. Meantime, top-of-the-agenda items for the Putin-Rouhani confab can be expected to include the prospects for multilateral talks about Iran’s contested nuclear program and the ongoing civil war in Syria.
— August 12-16: The Palais des Nations in Geneva, Switzerland, will play host to a five-day “Meeting of Experts” on the Biological Weapons Convention, sponsored by the BWC Implementation Support Unit. The event, to be chaired by Judit Körömi of Hungary, is to consider ways to strengthen cooperation and assistance; review new developments in BWC-related science and technology; and discuss how to enable greater participation in confidence-building measures.
— August 13: How important are the perceptions of leading decision-makers when it comes to setting national policy agendas? Jung Joo Kwon, a Korea Foundation junior scholar at the Wilson Center, will use game theory to help assess perceptions and misperceptions swirling around North Korea’s third nuclear crisis. James Person of the center’s History and Public Policy Program will chair the Washington session and offer remarks on Kwon’s analysis.
— August 13-15: Six United Nations specialists on sanctions against North Korea are to visit Panama for an inquiry on the recent discovery of an undisclosed shipment of weapon systems from Cuba to Pyongyang, as cargo vessel passed through the iconic Central American canal. The investigators are to follow up the trip with an initial report — and, later, a fuller exposition — on their findings.
— August 13-15: Cho Tae-yong, South Korea’s lead negotiator in the six-party talks aimed at denuclearizing the North, is to meet with his Russian equivalent, Igor Vladimirovich Morgulov, and other government officials in Moscow to discuss latest developments and coordinate on policy.
— August 15: Focusing more on the southern end of the Korean Peninsula, Congressional Research Service policy analyst Mark Holt will discuss “challenges for congressional action” in extending the U.S.-South Korea nuclear trade agreement. Washington and Seoul decided earlier this year to seek a simple two-year extension of their soon-to-expire existing cooperation pact, as a negotiated agreement about the terms of a renewal accord has thus far eluded them. The U.S.-Korea Institute at the Johns Hopkins School of Advanced International Studies has partnered with the Global America Business Institute to sponsor the event in Washington.
What We're Following See More »
Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.